ALNY
ALNYLAM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$162.86
+1.86%Leverage
- Debt / equity
- 0.35x
- Net debt / equity
- -0.14x
- Debt / assets
- 0.16x
- Debt / EBITDA
- 1.01x
- Net debt / EBITDA
- -0.39x
Liquidity & coverage
- Current ratio
- 2.48x
- Quick ratio
- 2.43x
- Cash ratio
- 1.74x
- Interest coverage
- 2.68x
- EBITDA / interest
- 3.42x
- Working capital
- $3.0B
Cash & dividend
- FCF / debt
- 0.40x
- Cash flow / debt
- 0.52x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026